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  The clinical effectiveness of oral administration of ONO－995 tablets was determined in 16 patients
with arefiexic neurogenic bladders， by means of assessing the improvement of their subjective symptoms，
amoant of residual urine and cystometric findings． An irnprovement in subjective symptoms was
seen in 70f thc l 6 patients， and more than 30％decrease in residual u血e in the othcr g patients．
An increase in pressure amplitude as evidenced by the difference between the maxi皿um voiding pressure
and maximum resting pressure on cystometry was observed in 9 patients． A slight increase in the
maximum urethral pressure was observed in 8 of the 13 patients selected for the urethral pressure
profile study． These results suggest that ONO－995 increases both urethral resistance and detrusor
contraction． When irnprovement of subjective symptoms showing an increase in pressure amplitude
by more than 6 cm H20 was evaluated as effective， the effective rate was 43．80／o ． There was no serious
adverse・reaction．
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検 査 方 法
 自覚症状は，とくに排尿困難について患者に聴取
し，改善，やや改善，不変に分けた．残尿量は排尿不











番 自排量 残尿量 残．尿率最大膀胱容鐙最大静止圧 簸高意識圧 収縮振幅最商尿道内圧
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Table 3．有効性の総合的評価
    自覚症状の番号    改 善 度
残尿減少率  振幅増加

















 改善  （十）
 改善  （十）
 改善  （十）
やや改善（土）
 改善  （十）
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